Soltis Investment Advisors LLC Bristol Myers Squibb CO Transaction History
Soltis Investment Advisors LLC
- $941 Million
- Q2 2024
A detailed history of Soltis Investment Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 6,809 shares of BMY stock, worth $346,714. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,809
Previous 6,178
10.21%
Holding current value
$346,714
Previous $335,000
15.82%
% of portfolio
0.03%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.08 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.66 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.8 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.01 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $108B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...